#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Advanced systemic mastocytosis Testicular leiomyosarcoma Extra-osseous Ewing's sarcoma metastatic Myasthenia gravis Juvenile idiopathic arthritis Undifferentiated sarcoma Choroidal dystrophy Squamous cell carcinoma of the oral cavity Angiosarcoma Adrenocortical carcinoma Endometrial cancer recurrent Ureteric cancer Neuromyelitis optica spectrum disorder Prostate cancer Giant cell tumour of tendon sheath More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Diagnostics Angiosarcoma metastatic – Diagnostics Congenital nephrogenic diabetes insipidus – Treatment Congenital hypotransferrinaemia – Trials in Disease Richter’s syndrome Cytokine release syndrome – Trials in Disease Pemphigoid – Basic Information Acquired haemophilia – Life with Disease Advanced systemic mastocytosis – Life with Disease Familial haemophagocytic lymphohistiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fenfluramine Hydrochloride Avelumab MAGNESIUM ACETATE TETRAHYDRATE Alizapride Salbutamol Sulfate Eplontersen Mitotane Ceritinib RO7837195 Alks 2680 ALXN2420 HYDROMORPHONE HYDROCHLORIDE Evolocumab Nms-03305293 Sirolimus Balstilimab Pemafibrate Nizaracianine Triflutate Ddcart‐Cd19 ARTICAINE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Deafness neurosensory Somatic symptom disorder Retroperitoneal cancer Ligament operation Rhabdomyosarcoma recurrent Lichen planopilaris Aortic valve stenosis Metastatic neoplasm Pharyngeal cancer stage II Chondrosarcoma Gout Lupus nephritis Cervical dysplasia Myxofibrosarcoma Arthralgia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Rifabutin plus drug combination for adult patients with hospital‑acquired and ventilator‑associated pneumonia caused by carbapenem‑resistant Acinetobacter baumannii

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pneumonia bacterial
    Investigated Drugs:
    • POLYMYXIN B SULFATE
    • Rifabutin
    • SULBACTAM SODIUM
    Croatia Greece

  • Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Clarithromycin
    • Esomeprazole
    Greece

  • Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ciprofloxacin
    Belgium

  • Comparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Pivmecillinam Hydrochloride
    • Ampicillin Sodium
    • Betamethasone Valerate
    Denmark

  • A study to compare weekly or event-based use of doxycycline to prevent sexually transmitted infections in men who have sex with men and transgender women using HIV prevention medication.

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Doxycycline
    Belgium

  • Comparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis
    Investigated Drugs:
    • Ceftriaxone
    • Lidocaine Hydrochloride
    • Ceftriaxone Sodium
    Spain
1 2 3 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!